Welcome to CDC Stacks | Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008 - 7015 | Stephen B. Thacker CDC Library collection | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008
Filetype[PDF - 1.03 MB]


Details:
  • Corporate Authors:
    United States, Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.), Immunization Safety Office. ; ... More ▼
  • Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 57, no. RR-7
  • Document Type:
  • Description:
    Introduction -- Primary Changes and Updates in the Recommendations -- Influenza and Its Burden 3 -- Options for Controlling Influenza -- Comparison of LAIV with Inactivated Influenza Vaccine -- Cost-Effectiveness of Influenza Vaccine -- Vaccination Coverage Levels -- -- Recommendations for Using Inactivated and Live, Attenuated Influenza Vaccines -- Target Groups for Vaccination -- Additional Information Regarding Vaccination of Specific Populations -- Inactivated Influenza Vaccine Recommendations -- Live, Attenuated Influenza Vaccine Recommendations -- Recommended Vaccines for Different Age Groups -- Influenza Vaccine Supply and Timing of Annual Influenza Vaccination -- Strategies for Implementing Vaccination Recommendations in Health-Care Settings -- Future Directions for Research and Recommendations Related to Influenza Vaccine -- -- Recommendations for Using Antiviral Agents for Influenza -- Antiviral Agents for Influenza -- Role of Laboratory Diagnosis -- Antiviral Drug-Resistant Strains of Influenza Virus Indications for Use of Antivirals When Susceptibility Exists -- Dosage -- Route -- Pharmacokinetics -- Side Effects and Adverse Reactions -- Use During Pregnancy -- Drug Interactions -- -- Information Regarding the Vaccines for Children Program -- -- Sources of Information Regarding Influenza and Its Surveillance -- -- Reporting of Adverse Events Following Vaccination -- -- Additional Information Regarding Influenza Virus Infection Control Among Specific Populations -- -- References

    "This report updates the 2007 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2007;56[No. RR-6]). The 2008 recommendations include new and updated information. Principal updates and changes include 1) a new recommendation that annual vaccination be administered to all children aged 5--18 years, beginning in the 2008--09 influenza season, if feasible, but no later than the 2009--10 influenza season; 2) a recommendation that annual vaccination of all children aged 6 months through 4 years (59 months) continue to be a primary focus of vaccination efforts because these children are at higher risk for influenza complications compared with older children; 3) a new recommendation that either trivalent inactivated influenza vaccine or live, attenuated influenza vaccine (LAIV) be used when vaccinating healthy persons aged 2 through 49 years (the previous recommendation was to administer LAIV to person aged 5--49 years); 4) a recommendation that vaccines containing the 2008--09 trivalent vaccine virus strains A/Brisbane/59/2007 (H1N1)-like, A/Brisbane/10/2007 (H3N2)-like, and B/Florida/4/2006-like antigens be used; and, 5) new information on antiviral resistance among influenza viruses in the United States. Persons for whom vaccination is recommended are listed in boxes 1 and 2. These recommendations also include a summary of safety data for U.S. licensed influenza vaccines. This report and other information are available at CDC's influenza website (http://www.cdc.gov/flu), including any updates or supplements to these recommendations that might be required during the 2008--09 influenza season. Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information. " - p. 1

  • Supporting Files:
    No Additional Files
  1. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007
  2. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  3. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  4. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  5. Using live, attenuated influenza vaccine for prevention and control of influenza; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)
  6. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  7. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  8. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  9. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  10. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  11. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  12. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  13. Prevention and control of influenza; recommendations of the Immunization Practices Advisory Committee (ACIP)